Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rocco Totaro

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Frontiers in Psychiatry|July 15, 2025
Investigating depression in multiple sclerosis: an Italian Delphi consensus on clinical manifestations, diagnosis and treatmentAntonio Bruno, Ettore Dolcetti, Pietro Annovazzi, et al.
Journal of Neurology|July 29, 2024
Effects of fingolimod on focal and diffuse damage in patients with relapsing-remitting multiple sclerosis - The "EVOLUTION" studyMassimo Filippi, Elisabetta Pagani, Renato Turrini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2010
The prevalence of multiple sclerosis in central ItalyEnrico Millefiorini, Antonio Cortese, Simone Di Rezze, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 8, 2021
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis PatientsAssunta Bianco, Matteo Lucchini, Rocco Totaro, et al.
Journal of Translational Medicine|April 20, 2011
Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patientsValentina Durastanti, Alessandra Lugaresi, Placido Bramanti, et al.
Journal of Neurology|July 10, 2026
Subcutaneous natalizumab administration in relapsing-remitting multiple sclerosis: results of EASIER 2 studyMassimo Filippi, Luigi M E Grimaldi, Vincenzo Brescia Morra, et al.
Journal of Neurology|August 27, 2024
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA)Clara Grazia Chisari, Maria Pia Amato, Alessia Di Sapio, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 10, 2014
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugsEmilio Portaccio, Angelo Ghezzi, Bahia Hakiki, et al.
BMC Neurology|January 2, 2013
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort studyLuisa Pastò, Emilio Portaccio, Angelo Ghezzi, et al.
BMC Neurology|June 3, 2014
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric studyChiara Pecori, Marta Giannini, Emilio Portaccio, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Frontiers in Psychiatry|July 15, 2025
Investigating depression in multiple sclerosis: an Italian Delphi consensus on clinical manifestations, diagnosis and treatmentAntonio Bruno, Ettore Dolcetti, Pietro Annovazzi, et al.
Journal of Neurology|July 29, 2024
Effects of fingolimod on focal and diffuse damage in patients with relapsing-remitting multiple sclerosis - The "EVOLUTION" studyMassimo Filippi, Elisabetta Pagani, Renato Turrini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2010
The prevalence of multiple sclerosis in central ItalyEnrico Millefiorini, Antonio Cortese, Simone Di Rezze, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 8, 2021
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis PatientsAssunta Bianco, Matteo Lucchini, Rocco Totaro, et al.
Journal of Translational Medicine|April 20, 2011
Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patientsValentina Durastanti, Alessandra Lugaresi, Placido Bramanti, et al.
Journal of Neurology|July 10, 2026
Subcutaneous natalizumab administration in relapsing-remitting multiple sclerosis: results of EASIER 2 studyMassimo Filippi, Luigi M E Grimaldi, Vincenzo Brescia Morra, et al.
Journal of Neurology|August 27, 2024
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA)Clara Grazia Chisari, Maria Pia Amato, Alessia Di Sapio, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 10, 2014
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugsEmilio Portaccio, Angelo Ghezzi, Bahia Hakiki, et al.
BMC Neurology|January 2, 2013
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort studyLuisa Pastò, Emilio Portaccio, Angelo Ghezzi, et al.
BMC Neurology|June 3, 2014
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric studyChiara Pecori, Marta Giannini, Emilio Portaccio, et al.
Pageof 7